How should I write a prescription for methocarbamol 750 mg tablets for an adult, specifying dosing three times daily as needed, a 30‑tablet supply, refills, and dose adjustments for hepatic or renal impairment?

Writing a Prescription for Methocarbamol 750 mg

For an adult patient, prescribe methocarbamol 750 mg tablets with an initial dosage of 2 tablets four times daily (6 grams per day) for the first 48–72 hours, then reduce to a maintenance dose of 1 tablet every 4 hours or 2 tablets three times daily (approximately 4 grams per day). 1

Prescription Components

Drug Name and Strength

• Methocarbamol 750 mg tablets 1

Initial Dosing (First 48–72 Hours)

• 2 tablets four times daily (QID) 1
• This provides 6 grams per day 1
• For severe conditions, up to 8 grams per day may be administered 1

Maintenance Dosing (After 48–72 Hours)

• 1 tablet every 4 hours OR 2 tablets three times daily (TID) 1
• This provides approximately 4 grams per day 1

Quantity and Refills

• For a 30-tablet supply at maintenance dosing (TID): This provides a 5-day supply
• For three times daily dosing: Dispense #60 tablets for a 10-day supply, or #90 tablets for a 15-day supply
• Refills: Specify the number of refills based on the expected duration of therapy (typically 0–2 refills for acute musculoskeletal conditions)

Specific Prescription Format

Write the prescription as:

• Methocarbamol 750 mg tablets
• Sig: Take 2 tablets by mouth four times daily for 3 days, then take 2 tablets by mouth three times daily as needed for muscle spasm
• Disp: 30 tablets (or adjust based on treatment duration)
• Refills: 0–2 (based on clinical need)

Dose Adjustments for Organ Impairment

Hepatic Impairment

• No specific dose adjustment is provided in the FDA labeling for methocarbamol 1
• Use with caution and monitor closely, as hepatic metabolism may be affected 2, 3

Renal Impairment

• No specific dose adjustment is provided in the FDA labeling for methocarbamol 1
• However, caution is warranted as the intravenous formulation contains polyethylene glycol (PEG), which has been implicated in metabolic acidosis and nephrotoxicity in patients with renal impairment 4
• For oral formulations, consider monitoring renal function if used chronically 5

Important Prescribing Considerations

Clarity of Instructions

• Use explicit language specifying "three times daily" or "four times daily" rather than "TID" or "QID" alone to improve patient comprehension 6
• Avoid hourly interval instructions (e.g., "every 6 hours") as these are frequently misunderstood by patients (77% misinterpretation rate) 7
• Specify "by mouth" or "orally" to avoid confusion 6

Duration of Therapy

• Methocarbamol is typically used for acute musculoskeletal conditions 1
• The high initial dose (6–8 grams/day) should only be used for 48–72 hours 1
• Transition to maintenance dosing (4 grams/day) thereafter 1

Storage and Dispensing

• Store at 20°–25°C (68°–77°F) 1
• Dispense in a tight container 1